share_log

Advent Technologies Hldgs Analyst Ratings

Benzinga ·  Aug 17, 2023 18:10
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
08/17/2023 -3.23% Jefferies $4 → $0.6 Downgrades Buy → Hold
10/25/2022 2641.94% Credit Suisse $18 → $17 Maintains Neutral
06/16/2022 545.16% Jefferies $11.2 → $4 Maintains Buy
03/19/2021 2803.23% Jefferies → $18 Initiates Coverage On → Buy

What is the target price for Advent Technologies Hldgs (ADN)?

The latest price target for Advent Technologies Hldgs (NASDAQ: ADN) was reported by Jefferies on August 17, 2023. The analyst firm set a price target for $0.60 expecting ADN to fall to within 12 months (a possible -3.23% downside). 2 analyst firms have reported ratings in the last year.

What is the most recent analyst rating for Advent Technologies Hldgs (ADN)?

The latest analyst rating for Advent Technologies Hldgs (NASDAQ: ADN) was provided by Jefferies, and Advent Technologies Hldgs downgraded their hold rating.

When is the next analyst rating going to be posted or updated for Advent Technologies Hldgs (ADN)?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Advent Technologies Hldgs, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Advent Technologies Hldgs was filed on August 17, 2023 so you should expect the next rating to be made available sometime around August 17, 2024.

Is the Analyst Rating Advent Technologies Hldgs (ADN) correct?

While ratings are subjective and will change, the latest Advent Technologies Hldgs (ADN) rating was a downgraded with a price target of $4.00 to $0.60. The current price Advent Technologies Hldgs (ADN) is trading at is $0.62, which is out of the analyst's predicted range.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment